Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
More stories
The rising retirement rate is changing the U.S. workforce
The average number of baby boomers who retire from the U.S. work force has been slowly growing over the last 10 years, as the population that “boomed” after the second world war have reached retirement age. But 2020 saw a big jump in the retirement rate, according to Pew Research Center, with over 3 million more people retiring than in 2019. Some workers left the labor force by choice; others were forced into early retirement.
Workers compensation.com: WC Experts Opine on Latest Guidance on ADA and COVID-19 Long Haulers
People suffering with lingering symptoms after having COVID-19 may be covered under the Americans with Disabilities Act.
Post-Covid Conundrum
Presented by: Tammy Bradly, VP Clinical Product Development
State by State Marijuana Laws
After a year of immense change, the United States continues to battle the COVID-19 pandemic and the opioid crisis.
Dental Trauma and Facial Injuries
CE credit is not available for previously recorded sessions.
MGC Acquires QualCare Alliance Networks Inc.
Mitchell | Genex | Coventry completes the acquisition of QualCare Alliance Networks Inc. demonstrating the company's commitment to network expansion.